**Question:** An adult male patient presented in the OPD with complaints of cough and fever for 3 months and intermittent haemoptysis. His sputum was positive for AFB. On probing, it was found that he had already received treatment with RHZE for 3 weeks from a nearby hospital and discontinued. How will you categorize and manage the patient -

A. Resistance
B. Relapse
C. Failure
D. Superimposed infection

**Correct Answer:**

**Core Concept:**

Tuberculosis (TB) is a severe infectious disease caused by Mycobacterium tuberculosis. Treatment for TB usually involves a combination of drugs, including isoniazid (H), rifampicin (R), pyrazinamide (Z), and ethambutol (E). The DOTS (Directly Observed Treatment Short-course) strategy is widely used for TB management, ensuring patients adhere to treatment regimens and preventing drug resistance.

**Why the Correct Answer is Right:**

The patient has received RHZE treatment for 3 weeks and then discontinued, which is a significant concern. In the DOTS strategy, patients must complete their full treatment course (6 months for pulmonary TB) to ensure optimal cure rates and prevent the development of drug resistance. In this case, the patient discontinued treatment prematurely, which increases the likelihood of treatment failure and drug resistance.

**Why Each Wrong Option is Incorrect:**

A. Drug resistance is not an appropriate category for this patient, as they have not been treated with the full regimen and discontinued treatment prematurely, increasing the risk of treatment failure and drug resistance.

B. Relapse is not the correct category for this patient, as they have already completed the initial treatment and discontinued it, rather than experiencing a relapse of the infection.

C. Treatment failure is not the correct category for this patient, as the cause of the patient's symptoms and treatment discontinuation is not due to treatment failure but due to premature discontinuation.

D. Superimposed infection is not the correct category for this patient, as the presented symptoms and treatment history suggest drug resistance or treatment failure due to premature discontinuation, not superimposed infection.

**Clinical Pearl:**

Ensuring patients adhere to full TB treatment courses is crucial to prevent drug resistance and treatment failure. Instructing patients on the importance of completing the full course and monitoring their progress is essential for optimal treatment outcomes. Instructing them on the need for continued DOTS (Directly Observed Treatment Short-course) supervision to prevent treatment failure and drug resistance is vital in TB management.